Dietary choline and betaine intake, cardio-metabolic risk factors and prevalence of metabolic syndrome among overweight and obese adults. 2023

Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
Department of Cardiovascular Surgery, Kashan University of Medical Sciences, Kashan, Iran.

BACKGROUND Choline is an important metabolite involved in phospholipids synthesis, including serum lipids, and is the immediate precursor of betaine. There are numerous studies with inconsistent results that evaluated the association between dietary choline intakes with cardiovascular risk factors. In addition, the association between dietary betaine and choline intakes with cardio-metabolic risk factors is not well studied. In the current study, our aim was to evaluate dietary choline and betaine intakes in the usual diet of obese individuals and to assess its association with serum lipids, blood pressure and glycemic markers among obese individuals. METHODS We recruited a total number of 359 obese people aged between 20 and 50 years in the present study. A semi-quantitative food frequency questionnaire (FFQ) was used for dietary assessment; dietary choline and betaine intakes were calculated using the United States Department of Agriculture (USDA) database. National cholesterol education program adult treatment panel (NCEP-ATP)-III criteria was used metabolic syndrome (MetS) definition. Enzymatic methods were used to assess biochemical variables. Body composition was measured with the bioelectrical impedance analysis (BIA) method. RESULTS Higher body mass index (BMI), waist to hip ratio (WHR), fat-free mass (FFM) and basal metabolic rate (BMR) were observed in higher tertiles of dietary choline intake (P < 0.01). There was no significant difference in terms of biochemical parameters among different tertiles of dietary choline intake, while systolic blood pressure (SBP) and diastolic blood pressure (DBP) were reduced in higher betaine tertiles (P < 0.05). For total dietary choline and betaine intakes, there was a reduction in DBP and low density lipoprotein (LDL) concentrations (P < 0.05). Also, a non-significant reduction in serum total cholesterol (TC), triglyceride (TG) and MetS prevalence was observed in higher tertiles of dietary choline and betaine intakes. After classification of the study population according to MetS status, there was no significant difference in biochemical variables in subjects with MetS (P > 0.05), while in the non-MetS group, SBP, DBP, TG and insulin levels reduced in higher tertiles of dietary betaine and choline (P > 0.05). CONCLUSIONS According to our findings, higher dietary intakes of choline and betaine were associated with lower levels of blood pressure and LDL concentrations among obese individuals. Further studies are warranted to confirm the results of the current study.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002794 Choline A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Bursine,Fagine,Vidine,2-Hydroxy-N,N,N-trimethylethanaminium,Choline Bitartrate,Choline Chloride,Choline Citrate,Choline Hydroxide,Choline O-Sulfate,Bitartrate, Choline,Chloride, Choline,Choline O Sulfate,Citrate, Choline,Hydroxide, Choline,O-Sulfate, Choline
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004435 Eating The consumption of edible substances. Dietary Intake,Feed Intake,Food Intake,Macronutrient Intake,Micronutrient Intake,Nutrient Intake,Nutritional Intake,Ingestion,Dietary Intakes,Feed Intakes,Intake, Dietary,Intake, Feed,Intake, Food,Intake, Macronutrient,Intake, Micronutrient,Intake, Nutrient,Intake, Nutritional,Macronutrient Intakes,Micronutrient Intakes,Nutrient Intakes,Nutritional Intakes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000083202 Cardiometabolic Risk Factors A cluster of personal behavior or lifestyle, environmental exposure, inborn or inherited conditions and characteristics, which, on the basis of epidemiological evidence, is known to be associated with CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. Cardiometabolic Risk Factor,Factor, Cardiometabolic Risk,Factors, Cardiometabolic Risk,Risk Factor, Cardiometabolic,Risk Factors, Cardiometabolic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001622 Betaine A naturally occurring compound that has been of interest for its role in osmoregulation. As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1341) Lycine,Oxyneurine,Acidin-Pepsin,Betaine Hydrochloride,C.B.B.,Citrate de Bétaïne Beaufour,Citrate de Bétaïne UPSA,Cystadane,Glycine Betaine,Hepastyl,Novobetaine,Scorbo-bétaïne,Stea-16,Acidin Pepsin,AcidinPepsin,Betaine, Glycine,Hydrochloride, Betaine,Scorbo bétaïne,Scorbobétaïne,Stea 16,Stea16

Related Publications

Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
February 2010, Metabolic syndrome and related disorders,
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
April 2018, Nutrients,
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
March 2019, BMC pediatrics,
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
July 2021, BMC endocrine disorders,
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
January 2015, Revista brasileira de epidemiologia = Brazilian journal of epidemiology,
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
May 2010, Journal of clinical hypertension (Greenwich, Conn.),
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
May 2007, Obesity (Silver Spring, Md.),
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
January 2013, PloS one,
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
September 2019, Diabetes research and clinical practice,
Mohammad Sadegh Pour Abbasi, and Ayda Zahiri Tousi, and Yalda Yazdani, and Sahar Vahdat, and Farshad Gharebakhshi, and Negin Nikrad, and Ali Manzouri, and Abnoos Mokhtari Ardekani, and Faria Jafarzadeh
January 2013, Nutrition journal,
Copied contents to your clipboard!